90 related articles for article (PubMed ID: 38442157)
1. Involvement of adenomatous polyposis coli in colorectal tumorigenesis.
Jaiswal AS; Balusu R; Narayan S
Front Biosci; 2005 May; 10():1118-34. PubMed ID: 15769611
[TBL] [Abstract][Full Text] [Related]
2. Biology of the adenomatous polyposis coli tumor suppressor.
Goss KH; Groden J
J Clin Oncol; 2000 May; 18(9):1967-79. PubMed ID: 10784639
[TBL] [Abstract][Full Text] [Related]
3. Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids.
Bonnet V; Maikranz E; Madec M; Vertti-Quintero N; Cuche C; Mastrogiovanni M; Alcover A; Di Bartolo V; Baroud CN
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2316500121. PubMed ID: 38442157
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous Polyposis Coli Modulates Actin and Microtubule Cytoskeleton at the Immunological Synapse to Tune CTL Functions.
Juzans M; Cuche C; Rose T; Mastrogiovanni M; Bochet P; Di Bartolo V; Alcover A
Immunohorizons; 2020 Jun; 4(6):363-381. PubMed ID: 32581014
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor adenomatous polyposis coli regulates T lymphocyte migration.
Mastrogiovanni M; Vargas P; Rose T; Cuche C; Esposito E; Juzans M; Laude H; Schneider A; Bernard M; Goyard S; Renaudat C; Ungeheuer MN; Delon J; Alcover A; Di Bartolo V
Sci Adv; 2022 Apr; 8(15):eabl5942. PubMed ID: 35417240
[TBL] [Abstract][Full Text] [Related]
6. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen-Fibrin Gels by Cytolytic and Non-Lytic Mechanisms.
Majumder B; Budhu S; Ganusov VV
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515143
[TBL] [Abstract][Full Text] [Related]
8. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
[TBL] [Abstract][Full Text] [Related]
9. T cell migration and effector function differences in familial adenomatous polyposis patients with
Cuche C; Mastrogiovanni M; Juzans M; Laude H; Ungeheuer MN; Krentzel D; Gariboldi MI; Scott-Algara D; Madec M; Goyard S; Floch C; Chauveau-Le Friec G; Lafaye P; Renaudat C; Le Bidan M; Micallef C; Schmutz S; Mella S; Novault S; Hasan M; Duffy D; Di Bartolo V; Alcover A
Front Immunol; 2023; 14():1163466. PubMed ID: 37533857
[TBL] [Abstract][Full Text] [Related]
10. In situ tumour arrays reveal early environmental control of cancer immunity.
Ortiz-Muñoz G; Brown M; Carbone CB; Pechuan-Jorge X; Rouilly V; Lindberg H; Ritter AT; Raghupathi G; Sun Q; Nicotra T; Mantri SR; Yang A; Doerr J; Nagarkar D; Darmanis S; Haley B; Mariathasan S; Wang Y; Gomez-Roca C; de Andrea CE; Spigel D; Wu T; Delamarre L; Schöneberg J; Modrusan Z; Price R; Turley SJ; Mellman I; Moussion C
Nature; 2023 Jun; 618(7966):827-833. PubMed ID: 37258670
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial drug screening on 3D Ewing sarcoma spheroids using droplet-based microfluidics.
Fevre R; Mary G; Vertti-Quintero N; Durand A; Tomasi RF; Del Nery E; Baroud CN
iScience; 2023 May; 26(5):106651. PubMed ID: 37168549
[TBL] [Abstract][Full Text] [Related]
12. A machine learning approach to discover migration modes and transition dynamics of heterogeneous dendritic cells.
Song T; Choi Y; Jeon JH; Cho YK
Front Immunol; 2023; 14():1129600. PubMed ID: 37081879
[TBL] [Abstract][Full Text] [Related]
13. Transient suppression of SUMOylation in embryonic stem cells generates embryo-like structures.
Cossec JC; Traboulsi T; Sart S; Loe-Mie Y; Guthmann M; Hendriks IA; Theurillat I; Nielsen ML; Torres-Padilla ME; Baroud CN; Dejean A
Cell Rep; 2023 Apr; 42(4):112380. PubMed ID: 37061916
[TBL] [Abstract][Full Text] [Related]
14. Functional precision oncology using patient-derived assays: bridging genotype and phenotype.
van Renterghem AWJ; van de Haar J; Voest EE
Nat Rev Clin Oncol; 2023 May; 20(5):305-317. PubMed ID: 36914745
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
